182 related articles for article (PubMed ID: 38491129)
21. Value of synthetic MRI quantitative parameters in preprocedural evaluation for TRUS/MRI fusion-guided biopsy of the prostate.
Cao H; Xu W; Xu Y; Rong X; Xiao X; Feng H; Wang X; Wang L; Qi T; Zhang L
Prostate; 2023 Aug; 83(11):1089-1098. PubMed ID: 37157155
[TBL] [Abstract][Full Text] [Related]
22. T1 Mapping and Amide Proton Transfer Weighted Imaging for Predicting Lymph Node Metastasis in Patients with Rectal Cancer.
Wang Y; Chen A; Hu W; Liu Y; Wang J; Lin L; Song Q; Liu A
Curr Med Imaging; 2024 Feb; ():. PubMed ID: 38343051
[TBL] [Abstract][Full Text] [Related]
23. CEST 2022 - Differences in APT-weighted signal in T1 weighted isointense lesions, black holes and normal-appearing white matter in people with relapsing-remitting multiple sclerosis.
Khormi I; Al-Iedani O; Casagranda S; Papageorgakis C; Alshehri A; Lea R; Liebig P; Ramadan S; Lechner-Scott J
Magn Reson Imaging; 2023 Oct; 102():212-221. PubMed ID: 37321380
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T.
Liu J; Li C; Chen Y; Lv X; Lv Y; Zhou J; Xi S; Dou W; Qian L; Zheng H; Wu Y; Chen Z
J Magn Reson Imaging; 2020 Apr; 51(4):1154-1161. PubMed ID: 31430008
[TBL] [Abstract][Full Text] [Related]
25. The Preoperative Diagnostic Performance of Multi-Parametric Quantitative Assessment in Rectal Carcinoma: A Preliminary Study Using Synthetic Magnetic Resonance Imaging.
Zhu K; Chen Z; Cui L; Zhao J; Liu Y; Cao J
Front Oncol; 2022; 12():682003. PubMed ID: 35707367
[TBL] [Abstract][Full Text] [Related]
26. Improved performance in differentiating benign from malignant sinonasal tumors using diffusion-weighted combined with dynamic contrast-enhanced magnetic resonance imaging.
Wang XY; Yan F; Hao H; Wu JX; Chen QH; Xian JF
Chin Med J (Engl); 2015 Mar; 128(5):586-92. PubMed ID: 25698188
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of low- and high-grade pediatric gliomas with amide proton transfer imaging: added value beyond quantitative relaxation times.
Zhang H; Yong X; Ma X; Zhao J; Shen Z; Chen X; Tian F; Chen W; Wu D; Zhang Y
Eur Radiol; 2021 Dec; 31(12):9110-9119. PubMed ID: 34047848
[TBL] [Abstract][Full Text] [Related]
28. Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS.
Gao W; Zhang S; Guo J; Wei X; Li X; Diao Y; Huang W; Yao Y; Shang A; Zhang Y; Yang Q; Chen X
J Magn Reson Imaging; 2021 Apr; 53(4):1118-1127. PubMed ID: 33179809
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.
Debnath A; Gupta RK; Singh A
Mol Imaging Biol; 2020 Apr; 22(2):384-396. PubMed ID: 31228076
[TBL] [Abstract][Full Text] [Related]
30. Improved differentiation between stage I-II endometrial carcinoma and endometrial polyp with combination of APTw and IVIM MR imaging.
Meng X; Tian S; Zhang Q; Chen L; Lin L; Li J; Shen Z; Wang J; Zhang Y; Song Q; Liu A
Magn Reson Imaging; 2023 Oct; 102():43-48. PubMed ID: 37054801
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of renal function in chronic kidney disease (CKD) by mDIXON-Quant and Amide Proton Transfer weighted (APTw) imaging.
Ju Y; Wang Y; Luo RN; Wang N; Wang JZ; Lin LJ; Song QW; Liu AL
Magn Reson Imaging; 2023 Nov; 103():102-108. PubMed ID: 37451519
[TBL] [Abstract][Full Text] [Related]
32. Amide Proton Transfer-weighted MRI in the Diagnosis of Major Salivary Gland Tumors.
Bae YJ; Choi BS; Jeong WJ; Jung YH; Park JH; Sunwoo L; Jung C; Kim JH
Sci Rep; 2019 Jun; 9(1):8349. PubMed ID: 31171835
[TBL] [Abstract][Full Text] [Related]
33. Whole-tumor amide proton transfer-weighted imaging histogram analysis to predict pathological extramural venous invasion in rectal adenocarcinoma: a preliminary study.
Chen W; Liu G; Chen J; Wei Q; Ye Y; Du X; Feng J; Yan Z; Deng K; Liu X
Eur Radiol; 2023 Jul; 33(7):5159-5171. PubMed ID: 36700956
[TBL] [Abstract][Full Text] [Related]
34. Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?
Yu H; Wen X; Wu P; Chen Y; Zou T; Wang X; Jiang S; Zhou J; Wen Z
Eur Radiol; 2019 Oct; 29(10):5298-5306. PubMed ID: 30887206
[TBL] [Abstract][Full Text] [Related]
35. Three-dimensional amide proton transfer-weighted and intravoxel incoherent motion imaging for predicting bone metastasis in patients with prostate cancer: A pilot study.
Hu W; Chen L; Lin L; Wang J; Wang N; Liu A
Magn Reson Imaging; 2023 Feb; 96():8-16. PubMed ID: 36375760
[TBL] [Abstract][Full Text] [Related]
36. Identification of ovarian endometriotic cysts in cystic lesions of the ovary by amide proton transfer-weighted imaging and R2∗ mapping.
Li Y; Lu X; Chen L; Zhang Q; Wang N; Wang J; Lin L; Hu G; Zhang Y; Liu A
Clin Radiol; 2023 Feb; 78(2):e106-e112. PubMed ID: 36334944
[TBL] [Abstract][Full Text] [Related]
37. Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging.
Arita Y; Takahara T; Yoshida S; Kwee TC; Yajima S; Ishii C; Ishii R; Okuda S; Jinzaki M; Fujii Y
Invest Radiol; 2019 Oct; 54(10):638-644. PubMed ID: 31192827
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the differentiation of benign and malignant breast lesions using synthetic relaxometry and the Kaiser score.
Meng L; Zhao X; Guo J; Lu L; Cheng M; Xing Q; Shang H; Wang K; Zhang B; Lei D; Zhang X
Front Oncol; 2022; 12():964078. PubMed ID: 36303839
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of Amide Proton Transfer-Weighted Imaging at 3T for Renal Masses: A Preliminary Study.
Xu Y; Wan Q; Ren X; Jiang Y; Yao J; Wu P; Shen A; Wang P
Curr Med Imaging; 2024 Apr; ():. PubMed ID: 38591213
[TBL] [Abstract][Full Text] [Related]
40. Synthetic MRI plus FSE-PROPELLER DWI for differentiating malignant from benign head and neck tumors: a preliminary study.
Wen B; Zhang Z; Zhu J; Liu L; Liu Z; Ma X; Wang K; Xie L; Zhang Y; Cheng J
Front Oncol; 2023; 13():1225420. PubMed ID: 37829331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
